Tirbanibulin: an alternative topical approach to manage superficial basal cell carcinoma. Comment on: 'Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment'.

Autor: Martora F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy., Ascierto P; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Costa C; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy., D'Andrea M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Di Trolio R; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Marasca C; Dermatology Unit, Medical Department, 'Antonio Cardarelli' National Hospital of Naples, Italy.
Jazyk: angličtina
Zdroj: Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Nov 16; Vol. 48 (12), pp. 1373-1374.
DOI: 10.1093/ced/llad271
Databáze: MEDLINE